YU25297A - A controlled release formulation for poorly soluble basic drugs - Google Patents

A controlled release formulation for poorly soluble basic drugs

Info

Publication number
YU25297A
YU25297A YU25297A YU25297A YU25297A YU 25297 A YU25297 A YU 25297A YU 25297 A YU25297 A YU 25297A YU 25297 A YU25297 A YU 25297A YU 25297 A YU25297 A YU 25297A
Authority
YU
Yugoslavia
Prior art keywords
poorly soluble
soluble basic
controlled release
release formulation
basic drugs
Prior art date
Application number
YU25297A
Other languages
Serbo-Croatian (sh)
Serbian (sr)
Inventor
W. Neville Broad
F. Alan Carmody
C. Liam Feely
C. Brian Withers
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Priority to YU25297A priority Critical patent/YU25297A/en
Publication of YU25297A publication Critical patent/YU25297A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Opisana je čvrsta oralna farmaceutska kompozicija sa kontrolisanim ispuštanjem, za smanjeni dnevni režim doziranja, kod koje je terapeutski sastojak jedan slabo rastvorljiv osnovni lek. Formulacija obuhvata primenu jedne vodorastvorljive alginatne soli, jedne kompleksne soli alginske kiseline i jedne organske karboksilne kiseline u smeši sa terapeutskim lekom. Takodje je opisano jedno posebno izvodjenje koje obuhvata dozni oblik za davanje jednom dnevno za klaritromicin.A solid controlled-release oral pharmaceutical composition for a reduced daily dosage regimen is described wherein the therapeutic ingredient is a poorly soluble basic drug. The formulation comprises administering one water-soluble alginate salt, one complex alginic acid salt and one organic carboxylic acid in a mixture with a therapeutic drug. Also disclosed is one particular embodiment comprising a once daily dosage form for clarithromycin.

YU25297A 1997-06-13 1997-06-13 A controlled release formulation for poorly soluble basic drugs YU25297A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
YU25297A YU25297A (en) 1997-06-13 1997-06-13 A controlled release formulation for poorly soluble basic drugs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU25297A YU25297A (en) 1997-06-13 1997-06-13 A controlled release formulation for poorly soluble basic drugs

Publications (1)

Publication Number Publication Date
YU25297A true YU25297A (en) 1999-11-22

Family

ID=47605184

Family Applications (1)

Application Number Title Priority Date Filing Date
YU25297A YU25297A (en) 1997-06-13 1997-06-13 A controlled release formulation for poorly soluble basic drugs

Country Status (1)

Country Link
YU (1) YU25297A (en)

Similar Documents

Publication Publication Date Title
TW429154B (en) A controlled release formulation for poorly soluble basic drugs
DE3872739D1 (en) SLOW RELEASE MEDICINAL PRODUCTS.
DE3689983D1 (en) Slow-release drug.
DE69919713D1 (en) PHARMACEUTICAL PREPARATION WITH DELAYED ACTIVE SUBSTANCE RELEASE OF PHENYTOIN SODIUM
DE69616795D1 (en) CONTROLLED-RELEASE FORMULATIONS FOR SLAVE-RELATED MEDICINAL SUBSTANCES
DK0841903T3 (en) Oral pharmaceutical preparations containing antimicrobially active active substances and sustained release pantoprazole
BR0112532A (en) Oral pharmaceutical composition, galenic system and composition use
FR2798289B1 (en) QUICKLY DELITING MOUTH GALENIC FORMS AND THEIR PREPARATION METHOD
DE60313359D1 (en) FENOFIBRATEDIC PHARMACEUTICAL COMPOSITION AND ITS PHYSIOLOGICALLY COMPATIBLE SALTS AND DERIVATIVES
ATE202926T1 (en) PHARMACEUTICAL EFFECTIVE PREPARATIONS CONTAINING BIODEGRADABLE MICROCAPSULES FOR CONTROLLED RELEASE OF ACTIVE INGREDIENTS
WO2001041742A3 (en) Antiviral medication
WO2001013898A3 (en) Pharmaceutical formulations with different release times
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
RS50298B (en) Directly compressibile matrix for controlled release of single daily doses of clarithromycin
YU25297A (en) A controlled release formulation for poorly soluble basic drugs
RS20060413A (en) Non-disintegrating oral solid composition of high dose of water soluble drugs
DE68907091T2 (en) Pharmaceutical tablets and capsule granules containing scleroglucan and active ingredient.
BR0201296A (en) Process for administering medication to miscellaneous animals
MY145885A (en) Controlled release formulations for oral administration